-
Daclatasvir, sold
under the
brand name Daklinza, is an
antiviral medication used in
combination with
other medications to
treat hepatitis C (HCV). The...
-
Daclatasvir/sofosbuvir (trade
names Darvoni, Sovodak) is a two-drug
combination for the
treatment of
hepatitis C. It is
given as a
single daily pill containing...
-
products include velpatasvir/sofosbuvir, sofosbuvir/
daclatasvir, osimertinib, crizotinib,
daclatasvir, sofosbuvir, afatinib, axitinib, brigatinib, baricitinib...
- Valganciclovirα
Entecavir Tenofovir disoproxil fumarate Daclatasvir Daclatasvir/sofosbuvir (
daclatasvir + sofosbuvir) Glecaprevir/pibrentasvir (glecaprevir...
- interferon-free
regimens with
other direct-acting
antiviral agents including daclatasvir. "Prescription medicines:
registration of new
chemical entities in Australia...
-
those who have been
previously infected. In
combination with ledipasvir,
daclatasvir or simeprevir, it is not
recommended with
amiodarone due to the risk...
- ledipasvir/sofosbuvir, or sofosbuvir/velpatasvir.
Sofosbuvir with
either daclatasvir or
simeprevir may also be used. HCV
genotype 1a (with
compensated cirrhosis):...
- post-marketing
trial of beclabuvir, in
combination with
asunaprevir and
daclatasvir, to
study the combination's
safety profile with
regard to
liver function...
- act on
dimers of NS5A. A
number of
modeling studies have
shown that
daclatasvir,
which is an NS5A inhibitor, only
binds to the "back-to-back" NS5A dimer...
- Lamivudine:
cytidine analogue RTI Zidovudine:
thymidine analogue RTI
Daclatasvir (Daklinza)
Hepatitis C NS5A
inhibitor Darunavir HIV
antiretroviral HIV...
